|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/22 | (2006.01) |
| A61K 9/52 | (2006.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 31/135 | (2006.01) | ||
| A61P 13/10 | (2006.01) |
| (11) | Number of the document | 1039882 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99946521.4 |
| Date of filing the European patent application | 1999-08-26 | |
| (97) | Date of publication of the European application | 2000-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2010-11-10 |
| (46) | Date of publication of the claims translation | 2011-02-25 |
| (86) | Number | PCT/SE1999/001463 |
| Date | 1999-08-26 |
| (87) | Number | WO 2000/012069 |
| Date | 2000-03-09 |
| (30) | Number | Date | Country code |
| 9802864 | 1998-08-27 | SE | |
| 9803871 | 1998-11-11 | SE |
| (72) |
NILVEBRANT, Lisbeth, SE
HALLÉN, Bengt, SE
OLSSON, Birgitta, SE
STRÖMBOM, Jan, SE
KREILGÅRD, Bo, DK
ORUP JACOBSEN, Lene, DK
HOECK, Ulla, DK
KRISTENSEN, Helle, DK
GREN, Torkel, SE
RINGBERG, Anders, SE
WIKBERG, Martin, SE
|
| (73) |
Pfizer Health AB,
112 87 Stockholm,
SE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapinė farmacinė forma, skirta tolterodino su kontroliuojamu atpalaidavimu vartojimui |
| THERAPEUTIC FORMULATION FOR ADMINISTERING TOLTERODINE WITH CONTROLLED RELEASE |
| Payment date | Validity (years) | Amount | |
| 2014-07-24 | 16 | 1200.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2015-04-16 |